HSP90AA1 and breast carcinoma: Additionally, resistance of breast cancer cells to chemotherapy is known to involve the phosphatidylinositol 3-kinase pathway [59], which is modulated by HSP90 by virtue of one of its key signaling proteins (AKT) being a client protein of HSP90.